Informa Markets in India is set to host the 18th edition of CPHI & PMEC India 2025, South Asia’s largest and most influential pharmaceutical event, from November 25–27, 2025, at the India Expo Mart, Greater Noida, Delhi NCR. Renowned as the Heart of Pharma, the event will unite 2,000+ exhibitors and 50,000+ professionals from over 120 countries, showcasing the complete pharmaceutical value chain, from formulations and APIs to machinery, packaging, cleanroom technologies, and contract services.
Mr. Yogesh Mudras, Managing Director, Informa Markets in India, highlighted the sector’s strong momentum, supported by the Union Budget 2025–26 allocation of ₹5,268 crore to the Department of Pharmaceuticals. He noted that India’s pharma market, projected to reach USD 130 billion by 2030 and USD 450 billion by 2047, is rapidly transitioning toward innovation-driven growth.
This year’s edition will spotlight key themes such as API self-reliance, sustainability, digitalization, and exports. Attendees can expect cutting-edge innovations in ESG compliance, clean manufacturing, and Pharma 4.0 technologies. The event will also welcome international exhibitors from China, Italy, Germany, Switzerland, and South Korea.
Popular knowledge platforms including the Pharma Leaders Roundtable, Women in Pharma Roundtable, Pharma Connect Congress, and the CPHI Pharma Awards will foster policy dialogue and strategic industry insights. Leading Indian and global companies across formulations and machinery will participate.
Supported by Pharmexcil, IPEC India, BDMAI, OPPI, FOPE, and IPA, CPHI & PMEC India 2025 reinforces India’s position as a global pharmaceutical powerhouse.